Request for Information - 218 Clinical IV Administration

### 🏥 Project Overview HealthShare NSW has issued a Request for Information (RFI) regarding the **218 Clinical IV Administration** contract. This RFI serves as a preliminary engagement step before a planned state-wide open market tender exercise scheduled for late 2026 or early 2027. The primary goal is to renew the current Standing Offer and ensure the continued supply of clinical intravenous administration products across all regions of New South Wales. ### 📋 Key Requirements & Scope The issuing organization is seeking to: * **Identify Market Interest:** Gauge the capacity of suppliers to respond to the upcoming large-scale tender. * **Gather Feedback:** Obtain industry suggestions on proposed product categories and sub-categories to refine the future procurement strategy. * **Forward Planning:** Provide the market with sufficient notice regarding the upcoming renewal of the Standing Offer. ### 🎯 Desired Outcomes Potential respondents should demonstrate their capability in healthcare services and medical supply chains. The evaluation of this RFI and the subsequent tender will focus on organizational capacity, methodology, sustainability, innovation, and risk management. This is a critical opportunity for healthcare suppliers to influence the structure of a major state-wide clinical contract. ### 🔍 Search Keywords HealthShare NSW, Clinical IV Administration, Intravenous Supplies, Healthcare Procurement, NSW Health Tender, Medical Devices, Standing Offer Renewal, RFI-2013700.